Latest Science

Clinical Drug Resistant PDX Models

An inevitable challenge emerges over time as tumors develop drug resistance, resulting in treatment failure.  The development of targeted therapies for overcoming drug resistance represents an unmet medical need. Patient-derived xenografts (PDXs) represent a powerful platform for cancer drug screening and biomarker discovery and are considered the gold standard of in vivo models for their …Read More >

Resource Type: Latest Science, Presentation
Resource Topic: Oncology, Tumor Models

VIEW

Creating a Biological Switch Using DEL Technology

In addition to identifying chemical starting points for early drug discovery processes, DNA-encoded library (DEL) technology has now expanded to new applications, including the discovery of bifunctional affinity ligands historically considered difficult to develop. At the 2024 Gordon Research Conference, WuXi AppTec presented a poster describing how DEL can enable the rapid discovery of novel …Read More >

Resource Type: Latest Science, Poster
Resource Topic: Biochemical Assays, CAR-T Cell, Cell-based Assays, DNA-Encoded Library (DEL), Hit Finding

VIEW

Recent Insights into Immuno-Oncology

The efficacy of CAR-T therapy is substantially influenced by the tumor microenvironment. This is particularly evident when PD-L1 is activated through CAR-T, leading to the inhibition of CAR-T cell activity via the PD-1 pathway. At the 2024 Recent Insights into Immuno-Oncology Conference, WuXi AppTec presented a poster describing an engineered CAR-T therapy that targets mesothelin …Read More >

Resource Type: Latest Science, Poster
Resource Topic: CAR-T Cell, Oncology

VIEW

Integrated Assay Platform Targeting HMPV Infection

Human metapneumovirus (HMPV) is a common cause of respiratory tract infections in young children, older adults, and people with weakened immune systems. HMPV is in the Pneumoviridae family along with the more commonly known respiratory syncytial virus (RSV).  Currently, there is no specific antiviral therapy to treat HMPV and no vaccine to prevent HMPV. At …Read More >

Resource Type: Latest Science, Poster
Resource Topic: Infectious Diseases, Respiratory Diseases

VIEW

Integrated Platform of siRNA Drug Discovery

RNA interference using small interfering RNA (siRNA) molecules has emerged as a promising therapeutic modality.  To accelerate the discovery of novel siRNAs, WuXi AppTec has established an integrated platform encompassing siRNA sequence design, chemical synthesis/modification, delivery ligand exploration, and activity/off-target assessment. At the TIDES USA 2024 Conference, our scientists presented a poster showcasing the effectiveness …Read More >

Resource Type: Latest Science, Poster
Resource Topic: Autoimmune and Inflammatory Diseases, Oligonucleotides

VIEW

DEL Empowers Discovery of Peptide Drugs

Despite the resurgence of interest in peptide therapeutics for historically “undruggable” targets, de novo discovery of peptide ligands remains a challenge.  Unlike traditional technologies, DNA-encoded libraries (DELs) predominantly employ unnatural amino acids, and the resulting cyclic peptide-like molecules which are generated display a wider range of chemical space and smaller ring sizes with improved physicochemical …Read More >

Resource Type: Latest Science, Poster
Resource Topic: DNA-Encoded Library (DEL), Peptides

VIEW

Integrated Screening in Hit Identification

Despite the availability of modern screening technologies, identification and optimization of hits against poorly druggable targets remains a significant challenge for drug discovery teams.  Generating hit matter and reference compounds with one screening technology and then screening with a second technology has the potential to be a powerful tool for researchers. At this year’s Oxford …Read More >

Resource Type: Latest Science, Poster
Resource Topic: DNA-Encoded Library (DEL), Hit Finding, Hit-to-Lead, Small Molecules

VIEW

Comprehensive Evaluation of Gout Models

Gout is a common type of inflammatory arthritis linked to abnormal uric acid metabolism, resulting in the accumulation of urate crystal deposits in joints. To support the development of effective gout therapies, precise animal models are needed to properly evaluate drug candidates. At IMMUNOLOGY2024, WuXi AppTec presented a poster highlighting the development of multiple preclinical …Read More >

Resource Type: Latest Science, Poster
Resource Topic: Autoimmune and Inflammatory Diseases, in vivo Pharmacology

VIEW

Preclinical Evaluation of JAK Inhibitors in an Atopic Dermatitis Model

Atopic dermatitis (AD) is a chronic, pruritic inflammatory skin condition that is characterized by recurrent eczematous lesions. Janus kinase (JAK) inhibitors have been found to be efficacious in treating AD, although their mechanism of action in AD is not fully understood. To support preclinical research in this area, WuXi AppTec presented a poster at IMMUNOLOGY2024 …Read More >

Resource Type: Latest Science, Poster
Resource Topic: Autoimmune and Inflammatory Diseases, in vivo Pharmacology

VIEW


Resource Topics
× peptide, amino acid

Contact An Expert Today!